Suppliers / Exela Pharma Sciences

Exela Pharma Sciences

United States 343 employees Updated 9 July 2026

Exela Pharma Sciences is a finished-dose manufacturer based in United States. It appears in 22 regulatory filings across 1 regulator, without an active US DMF or CEP on file.

0
active US DMFs
0
valid CEPs
0
registered plants
22
filings across 1 regulators

Filings and GMP by regulator

Regulator Filings GMP certificates
US FDA 22 None

Limited public record

Beyond the filing counts above, the public registers hold no plant, inspection or portfolio detail for this company as at 9 July 2026. We report that as a gap rather than inferring an answer.

Questions about Exela Pharma Sciences

Does Exela Pharma Sciences hold a US DMF or a CEP?
No active US drug master file or valid CEP is on record for Exela Pharma Sciences. It does have 22 filings with one regulator, so it is registered, just not with the two strong registers buyers usually screen on.
Where does Exela Pharma Sciences file?
Filings are on record with US FDA, 22 in total.

Answered from this company's own record. Where a register holds nothing, the question is not asked rather than answered with a zero. How we count our figures.

Comparing suppliers?

Choose your molecules and target markets. Exela Pharma Sciences comes back tiered against every other supplier able to file there.

Start for free
No sales call.

Open risk flags

  • One recent serious compliance event is on record.

Comparable suppliers

Aaa Pharmaceuticals also in United States Aarkish Pharmaceuticals NJ also in United States Abbott Laboratories also in United States Abon Pharmaceuticals also in United States Access Business Group also in United States

Ranked by shared active ingredients where we have them, otherwise by country and comparable credentials.

Sources on this page

FDA
Drug master files, establishment registration, inspection classifications
EDQM
Certificates of suitability